Ten Years Experience With Belatacept-Based Immunosuppression After Kidney Transplantation

BACKGROUND: Belatacept was approved for prevention of acute rejection in adult kidney transplantation in 2011 based on two randomized, controlled, multicenter phase 3 studies. Long-term experience over 10 years with belatacept-based immunosuppression after kidney transplantation has not been reporte...

Descripción completa

Detalles Bibliográficos
Autores principales: Grannas, Gerrit, Schrem, Harald, Klempnauer, Juergen, Lehner, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3935530/
https://www.ncbi.nlm.nih.gov/pubmed/24578751
http://dx.doi.org/10.14740/jocmr1697w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3935530/
https://www.ncbi.nlm.nih.gov/pubmed/24578751
http://dx.doi.org/10.14740/jocmr1697w

Ejemplares similares